1. Home
  2. LPSN vs ASMB Comparison

LPSN vs ASMB Comparison

Compare LPSN & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LPSN
  • ASMB
  • Stock Information
  • Founded
  • LPSN 1995
  • ASMB 2005
  • Country
  • LPSN United States
  • ASMB United States
  • Employees
  • LPSN N/A
  • ASMB N/A
  • Industry
  • LPSN EDP Services
  • ASMB Biotechnology: Pharmaceutical Preparations
  • Sector
  • LPSN Technology
  • ASMB Health Care
  • Exchange
  • LPSN Nasdaq
  • ASMB Nasdaq
  • Market Cap
  • LPSN 71.2M
  • ASMB 76.9M
  • IPO Year
  • LPSN 2000
  • ASMB 2010
  • Fundamental
  • Price
  • LPSN $0.86
  • ASMB $12.24
  • Analyst Decision
  • LPSN Hold
  • ASMB Strong Buy
  • Analyst Count
  • LPSN 4
  • ASMB 3
  • Target Price
  • LPSN $0.97
  • ASMB $33.00
  • AVG Volume (30 Days)
  • LPSN 728.0K
  • ASMB 19.9K
  • Earning Date
  • LPSN 05-07-2025
  • ASMB 05-08-2025
  • Dividend Yield
  • LPSN N/A
  • ASMB N/A
  • EPS Growth
  • LPSN N/A
  • ASMB N/A
  • EPS
  • LPSN N/A
  • ASMB N/A
  • Revenue
  • LPSN $292,025,000.00
  • ASMB $32,154,000.00
  • Revenue This Year
  • LPSN N/A
  • ASMB $10.82
  • Revenue Next Year
  • LPSN $2.35
  • ASMB N/A
  • P/E Ratio
  • LPSN N/A
  • ASMB N/A
  • Revenue Growth
  • LPSN N/A
  • ASMB 148.33
  • 52 Week Low
  • LPSN $0.52
  • ASMB $7.75
  • 52 Week High
  • LPSN $2.08
  • ASMB $19.93
  • Technical
  • Relative Strength Index (RSI)
  • LPSN 53.16
  • ASMB 57.05
  • Support Level
  • LPSN $0.77
  • ASMB $11.64
  • Resistance Level
  • LPSN $0.99
  • ASMB $14.80
  • Average True Range (ATR)
  • LPSN 0.06
  • ASMB 0.84
  • MACD
  • LPSN 0.01
  • ASMB 0.16
  • Stochastic Oscillator
  • LPSN 54.89
  • ASMB 48.59

About LPSN LivePerson Inc.

LivePerson Inc is the enterprise leader in digital customer conversation. The Conversational Cloud, the Company's enterprise-class digital customer conversation platform, is trusted by the world's top brands to accelerate their contact center transformation, orchestrate conversations across all channels, departments, and systems, increase agent productivity, and deliver more personalized, AI-empowered customer experiences. The company has a presence in the United Kingdom, Asia-Pacific, Latin America, and Europe.

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

Share on Social Networks: